Researchers have suggested that patients with favorable intermediate-risk prostate cancer could be treated with active surveillance, similar to the way in which patients with low-risk prostate cancer currently can be.
In the United States, stroke was the fourth leading cause of death in 2013 and about 800,000 people are affected each year. In 2010, deaths due to ischemic strokes which can be attributed to high tobacco consumption accounted for more cases in Russia, China and India than in the rest of the world.
Dementia is a topic that is aired with increasing frequency in the media – perhaps due to raised awareness but certainly as a response to demographic change. The subject also arises in the context of life and health insurance product development, underwriting and claims.
Obesity is a multi-factorial condition and the over-consumption of energy (calories) as sugar is a significant contributor to weight gain. When people take in more energy than they actually use up by body metabolism and physical activity, they create an imbalance. Sustained energy imbalance leads to an accumulation of excess body fat and weight gain over time.
The treatment of cancer is undergoing a major period of research and development with new treatments being introduced on a regular basis. Many of these are very expensive, with the cost of some new drugs running into tens of thousands of dollars. Cancer is highly emotive, with patients eager to benefit from the latest medical advances. It is therefore important that health underwriters and claims assessors have knowledge of these treatments.
This article introduces some types of treatment being used to combat cancer today. In future articles we will more fully explore each treatment type.
Hematuria is the finding of blood in the urine. It can either be quite obvious where blood is visible to the naked eye, or microscopic, where only a urinalysis picks up the findings (asymptomatic microscopic hematuria). Large amounts of blood can create a smoky reddish brown appearance to the urine, while microscopic hematuria may appear as completely normal.
The number of people who have had an experience of schizophrenia and are applying for life and disability insurance is small. Those that do represent a high-functioning cohort that are too often tarred with the stereotypes of poor outcome and high rates of suicide associated with the diagnosis. Rarely have these people been seen as individuals or had their risk appropriately assessed.